• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

    433.88 +1.10 (+0.25%)
    Streaming Delayed Price Updated: 12:53 PM EDT, Mar 11, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Madrigal Pharmaceuticals, Inc. - Common Stock

    6 Stocks Positioned to Soar as Investors Focus on MASH
    Investors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it's easy to see why obesity drugs including GLP-1 agonists have exploded in the marketplace. This class of... 
    Via TheNewswire.com
    News headline image
    7 Stocks That Will Drive the Weight Loss Drugs Market
    The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis. 
    Via MarketBeat
    Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/15 Morning Trading
    Via Investor Brand Network
    News headline image
    Analysts see over 50% gains in these 2 mid-cap biotech stocks
    The outlook for growth has made biotech one of the hottest investments of late - and Wall Street sees big comeback gains ahead in these two biotechs. 
    Via MarketBeat
    Topics Artificial Intelligence
    Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 9/13 Morning Trading
    Via Investor Brand Network
    Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/17 Morning Trading
    Via Investor Brand Network
    Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Making Surprising Moves in Tuesday Session
    Via Investor Brand Network
    Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Making Surprising Moves in Tuesday Session
    Via Investor Brand Network
    News headline image
    Want Diversified Upside in Biotechnology? Check out LABU
    Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. 
    Via MarketBeat
    Topics ETFs Stocks
    News headline image
    Why Did Viking Therapeutics Stock Skyrocket
    VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial. 
    Via MarketBeat
    News headline image
    Madrigal Pharmaceuticals (NASDAQ: MDGL) Reports Impressive Topline Results from Phase 3 Trial of Resmetirom to Treat NASH and Liver Fibrosis
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development 
    Via Spotlight Growth
    News headline image
    Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here's Why
    Madrigal Pharmaceuticals announced positive results for a major clinical trial and shares are up more than 200% because of it. 
    Via MarketBeat
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.